Stocks
Editas Medicine (EDIT) EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -188.1 | -219.6 | -163.1 | -233.1 | -148.6 | -101.2 | ||
| Changes by years, y/y, % | +44% | +17% | -26% | +43% | -36% | +2.6% | |||
Editas Medicine. EBITDA US GAAP, bln rub
Editas Medicine. EBITDA US GAAP, changes, %
Editas Medicine. EBITDA US GAAP, sum by quarters, bln rub
Editas Medicine (EDIT) EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| EBITDA, bln rub | ? | -49.4 | -22.0 | -5.28 | -23.4 | -19.5 | -101.2 | |
| Changes by years, y/y, % | -30% | -64% | -84% | -67% | -60% | |||
| Changes by quarters, q/q, % | -31% | -55% | -76% | +344% | -17% | |||
